We attended ASCO 2019. ASCO is the American Society of Clinical Oncology. ASCO hosts, next to many other activities around oncology, an annual meeting.
This meeting provides clinical updates and educational sessions for oncologists, nurses, researchers and everybody interested in oncology from around the world. The 2019 meeting hosted more than 40’000 participants, an increase of ca. 30% over the last 7 years. The growth of participants indicates the level of innovation and investments which flow into the sector. These aspects stayed the same compared to previous years. However, a lot of other things have changed in 2019.
Rarely are health inequalities more apparent than when walking around San Francisco during the J.P. Morgan Healthcare Conference. In our chart of the month, Raphael Oesch (Portfolio Manager), takes a look at the statistics and discusses some of the reasons behind the figures.
We recently attended the 41st J.P. Morgan Healthcare Conference in San Francisco, which took place from January 9th to January 12th 2023. Our overall conclusion from the conference is that the industry remains in good shape. The key themes that emerged during the week from a devices and services perspective were, the rise of value-based care and innovation & digitalisation. However, it also became clear that the macroeconomic environment is still the dominant force behind (sub) sector performance.
Day after day currently feels like a roller coaster ride, going up because of better than hoped for CPI numbers, down because of looming recession fears, and back up because of a less hawkish FED speech. Are we there yet? What do you think?